PaySign Inc

PaySign, Inc. engages in the provision of prepaid card programs and processing services for corporate, consumer and government applications. It specializes in corporate incentive products, payroll cards, general purpose re-loadable cards, and travel cards. It markets its prepaid solutions through its PaySign brand. The company was founded by Mark R. Newcomer and Daniel H. Spencer on August 24, 1995 and is headquartered in Henderson, NV.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

PaySign Inc (PAYS) reports robust Q4 earnings and growth outlook

PaySign Inc (PAYS) delivered a strong financial performance in Q4 2022, with revenue growth, profitability, and operational achievements.
The company's focus on expanding its plasma business and patient affordability programs has been key drivers of growth and market differentiation.
Looking ahead, PaySign aims for continued growth in 2023, supported by revenue projections and strategic initiatives to drive profitability and market expansion.

PaySign Inc reports strong revenue growth, eyes plasma business expansion

PaySign Inc's Q1 2023 performance reflects solid revenue growth and operational progress, despite facing margin and profitability challenges.
The company's strengths lie in the growth potential of its Plasma and Patient affordability businesses, along with strategic industry partnerships.
While challenges persist in maintaining margins and addressing profitability, PaySign Inc has opportunities to drive growth through new center openings and market expansion.
Overall, PaySign Inc's financial position remains stable with a focus on executing its growth strategies and enhancing profitability.

PaySign Inc reports strong Q2 revenue growth and expansion plans

PaySign Inc (PAYS) delivered robust revenue growth in Q2 2023, driven by strong performance in key segments and a focus on expanding its market presence.
While facing challenges such as a net loss and increased SG&A expenses, the company remains optimistic about its growth prospects and profitability trajectory.
By capitalizing on opportunities in plasma compensation and patient affordability segments, PaySign Inc aims to sustain its growth momentum and enhance shareholder value.

PaySign Inc (PAYS) reports strong Q3 earnings and growth prospects

PaySign Inc (PAYS) delivered robust financial results in Q3 2023, showcasing growth across key business segments.
Despite challenges such as new center openings and contract delays, the company remains focused on meeting its financial targets.
With a strong balance sheet, diversified revenue streams, and strategic outlook, PaySign Inc (PAYS) is well-positioned for future success.

PaySign Inc reports stellar Q4 results, eyes growth opportunities

PaySign Inc delivered strong financial results in Q4 2023, with notable revenue growth and net income increase, driven by the success of its plasma and patient affordability segments.
The company's strategic focus on revenue diversification, technology development, and market expansion positions it well for future growth and competitive advantage.
While facing challenges in sustaining growth rates and navigating competitive landscapes, PaySign has opportunities to capitalize on market demand, innovation, and ethical business practices to drive continued success.
Overall, PaySign's performance highlights operational excellence, strategic foresight, and a commitment to delivering value to stakeholders, setting a positive trajectory for 2024 and beyond.

PaySign Inc reports robust Q1 earnings, eyes growth opportunities

PaySign Inc delivered impressive financial results in Q1 2024, driven by strong revenue growth and improved profitability.
While facing challenges in sustaining growth and market competition, the company remains optimistic about future prospects.
Strategic expansion in key business segments and a positive market reception position PaySign Inc for continued success.

PaySign Inc (PAYS) reports stellar Q2 results and raises 2024 guidance

PaySign Inc demonstrated robust financial performance in Q2 2024, driven by strong revenue growth, improved profitability, and expansion of key client relationships. While facing some challenges in specific business segments, the company's strategic initiatives and raised guidance indicate a positive trajectory for future growth and success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Third Quarter 2024 Earnings Call.

Paysign to Host Third Quarter 2024 Earnings Call

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is Paysign (PAYS) Stock Undervalued Right Now?

Here is how Paysign, Inc. (PAYS) and Recruit Holdings Co., Ltd. (RCRRF) have performed compared to their sector so far this year.

Is Paysign (PAYS) Stock Outpacing Its Business Services Peers This Year?

Is Paysign (PAYS) Outperforming Other Business Services Stocks This Year?

Niche Focus: Paysign specializes in healthcare payment solutions, primarily in plasma donor compensation and patient affordability programs. Revenue Growth: Significant growth in the patient affordability segment is now a substantial part of total revenue. Financial Resilience: The company has shown strong revenue and margin recovery post-pandemic, with promising future growth.

Paysign: The Return Of The King Of Medical Fintech

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference.

Paysign, Inc. to Participate in the August 2024 Sidoti Micro-Cap Virtual Conference

GEO Group

Summit Therapeutics

Recent headlines have highlighted the shift many investors are making from large-cap to small cap stocks.

3 Small-Cap Stocks That Could Outperform the “Magnificent 7”

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference.

Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference

Paysign, Inc. (NASDAQ:PAYS ) Q2 2024 Earnings Conference Call July 31, 2024 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President of Patient Affordability Conference Call Participants Gary Prestopino - Barrington Research Operator Good afternoon. My name is Kevin, and I'll be your conference operator today.

Paysign, Inc. (PAYS) Q2 2024 Earnings Call Transcript

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. Reports Second Quarter 2024 Financial Results.

Paysign, Inc. Reports Second Quarter 2024 Financial Results

Bombardier Inc.

Celsius Holdings

Direct Digital Holdings

IAC/InterActiveCorp

AiHuiShou International Co Ltd

The broader market rally has left many investors wondering if there are any growth stocks to buy before a correction. I believe that there absolutely are.

7 Growth Stocks to Buy With $1,000 or You'll Be Kicking Yourself in 2025

Archer Aviation

ADC Therapeutics

Elutia Inc

Grab Holdings Ltd

National CineMedia

With growth stocks under $5, the focal point is rather obvious: putting woodwork on the ball as aggressively as possible. Of course, swinging for the fences comes with significant risks.

7 Growth Stocks to Buy for Under $5 for Massive Gains

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host Second Quarter 2024 Earnings Call.

Paysign to Host Second Quarter 2024 Earnings Call

EZCORP

QuickLogic

Stocks under $20 usually provide a very good balance of upside potential and safety. I believe it is worth looking into many stocks in this range, as many have been battered and are about to make a turnaround.

The 3 Best Stocks Under $20 for Small Account Growth

Genius Sports

Honest Co

When strategizing about which equities to acquire, it's natural to look at the usual suspects. Basically, these ideas attract the bulk of the spotlight.

3 Obscure Stocks That Could Make You a Millionaire

Cadiz

LENSAR Inc

Buying low-priced stocks with explosive potential is any investor's dream — but it's not easy. Many stocks trade under $10 in the market, yet not all are quality picks.

3 Under-$10 Stocks With the Potential to Make You a Millionaire

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25.

Paysign, Inc. to Participate in the 2024 Maxim Fintech Virtual Symposium, June 25

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced their participation in the iAccess Alpha Buyside Best Ideas Summer Conference, June 25-26, 2024. Jeff Baker, Paysign's Chief Financial Officer, will deliver a presentation at 2:30 p.m. EDT on June 25, and is available to host one-on-one meetings the following day, Ju.

Paysign, Inc. to Participate in the 2024 iAccess Alpha Buyside Best Ideas Summer Conference

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference.

Paysign, Inc. to Participate in the June 2024 Sidoti Small-Cap Virtual Investor Conference

Paysign, Inc. (NASDAQ:PAYS ) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Mark Newcomer - President and CEO Jeff Baker - CFO Matt Turner - President of Patient Affordability Matt Lanford - Chief Payments Officer Conference Call Participants Gary Prestopino - Barrington Research Jon Hickman - Ladenburg Thalmann Operator Good afternoon. My name is Kevin, and I'll be your conference operator today.

Paysign, Inc. (PAYS) Q1 2024 Earnings Call Transcript

First quarter 2024 total revenues of $13.2 million, up 30% from first quarter 2023 First quarter 2024 net income of $309 thousand, or diluted earnings per share of $0.01, versus net loss of $160 thousand, or diluted earnings per share of $(0.00) for first quarter 2023 First quarter 2024 Adjusted EBITDA of $1.7 million, up 135% from $720 thousand for first quarter 2023, while diluted Adjusted EBITDA per share was $0.03 versus $0.01 for first quarter 20231 Total plasma center count increased by five net new centers during first quarter 2024, exiting the quarter with 469 centers, contributing to an 11% increase in plasma revenue versus the same period last year Added 10 net new patient affordability programs during first quarter 2024, exiting the quarter with 53 active programs, leading to a 305% increase in pharma patient affordability revenue over the same period last year Exited the quarter with $7.0 million of unrestricted cash and zero debt First quarter 2024 gross dollar load volume was up 13% compared to first quarter 2023 First quarter 2024 gross spend volume was up 11% compared to first quarter 2023 First quarter 2024 average revenue per plasma center per month of $7,414, up 5%, versus $7,066 for the first quarter of 2023 First quarter 2024 patient affordability claim volume increased 235%, versus first quarter 2023 1 Adjusted EBITDA and Adjusted EBITDA per share are non-GAAP metrics used by management to gauge the operating performance of the business - see reconciliation of net income to Adjusted EBITDA at the end of the press release. HENDERSON, NV / ACCESSWIRE / May 7, 2024 / Paysign, Inc. (NASDAQ:PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services and integrated payment processing, today announced financial results for the first quarter 2024.

Paysign, Inc. Reports First Quarter 2024 Financial Results

HENDERSON, Nev.--(BUSINESS WIRE)--Paysign to Host First Quarter 2024 Earnings Call.

Paysign to Host First Quarter 2024 Earnings Call

Dada Nexus

iSun

Lesaka Technologies Inc

LiveOne

374Water Inc

If you're an investor with a high tolerance for risk and a desire for supersized returns, penny stocks should be at the top of your watchlist. While penny stocks are often associated with pump-and-dump schemes and companies on the verge of bankruptcy, there are some real hidden gems trading at bargain valuations that could potentially deliver astronomical returns within a few short years.

7 Penny Stocks That Can Turn $10,000 Into $100,000 by 2027

PaySign continues to experience double-digit net sales growth driven by investments in prepaid card-based payment solutions for the plasma donation industry. The company has a strong presence with 465 plasma centers and 6.4 million cardholders, as well as sponsorship from large banks and card companies. The recent acquisition of shares by PaySign may lead to increased demand for the stock and lower cost of capital.

Driving Growth And Innovation Are Drivers Of PaySign's Success In The Prepaid Card Industry

PaySign, Inc. (PAYS) Q4 2023 Earnings Call Transcript

News for PaySign Inc Stock (PAYS)